Lilly outlines $91B-$92B 2026 revenue outlook as Medicare GLP-1 Bridge and Foundayo rollout expand access

• "Q3 was another quarter of solid execution. We delivered strong financial results, raised our full year financial guidance, advanced our pipeline and expanded our manufacturing footprint." (Chairman, President & CEO David Ricks)

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.